Nuvectis Pharma, Inc.NVCTNASDAQ
LOADING
|||
Operating Income Growth Trend
Above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-18.18%
↑ 99% above average
Average (18q)
-1359.48%
Historical baseline
Range
High:51.48%
Low:-25717.39%
Volatility
-1895.5%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -18.18% |
| Q2 2025 | -18.44% |
| Q1 2025 | 13.66% |
| Q4 2024 | -47.95% |
| Q3 2024 | 6.12% |
| Q2 2024 | -5.62% |
| Q1 2024 | 35.97% |
| Q4 2023 | -11.50% |
| Q3 2023 | -6.69% |
| Q2 2023 | -40.75% |
| Q1 2023 | 39.50% |
| Q4 2022 | -14.15% |
| Q3 2022 | -66.19% |
| Q2 2022 | -21.32% |
| Q1 2022 | -30.02% |
| Q4 2021 | 51.48% |
| Q3 2021 | 21.39% |
| Q2 2021 | -25717.39% |
| Q1 2021 | 0.00% |